Point72 Middle East FZE’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-26,086
Closed -$931K 128
2023
Q4
$931K Buy
26,086
+21,674
+491% +$806K 0.03% 640
2023
Q3
$193K Sell
4,412
-7,199
-62% -$351K 0.01% 1025
2023
Q2
$573K Buy
+11,611
New +$535K 0.02% 738
2023
Q1
Sell
-1,869
Closed -$82.9K 1634
2022
Q4
$82.9K Buy
+1,869
New +$78.1K ﹤0.01% 1326

Other funds holding ATRC

Point72 Middle East FZE's ATRC Position: Q1 2024 in Review

Point72 Middle East FZE sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 26,086 shares — an estimated $931K sold.

Point72 Middle East FZE first reported a position in ATRC in Q4 2022 and held it in 4 quarters. The position peaked at $931K in Q4 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • Point72 Middle East FZE reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 26,086 AtriCure shares in Q1 2024, an estimated $931K.
  • Point72 Middle East FZE first reported a position in AtriCure in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's AtriCure position peaked at $931K in Q4 2023.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.